-
Other Name
-
Sponsor Type
-
Federal
-
Country
-
United States
-
Grant Types
-
Fellowship/Scholarship/Dissertation
Research Project
Training/Course
Workshop/Conference
Post-doctoral
Collaboration/Cooperative Agreement
Equipment/Facility/Organization
Publishing/Editorial
Other
Last modified on 2024-07-29 03:21:00
Description
**About NCATS**
Our mission is to turn research observations into health solutions through translational science. Our vision is more treatments for all people more quickly.
**Founding**
Then-NIH Director Francis S. Collins, M.D., Ph.D., published [the founding vision of NCATS](https://www.science.org/doi/full/10.1126/scitranslmed.3002747) on July 6, 2011. Our mission is to support the creation of innovative methods and technologies to speed the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.
Advisory bodies provided guidance and strategic counsel during the development of NCATS:
- Composed of independent experts, a working group of the [Advisory Committee to the NIH Director](http://acd.od.nih.gov/ "Members - NIH Advisory Committee to the Director") provided input on how NCATS might partner with the private sector and support the translational research enterprise.
- Composed of NIH leadership, the NIH CTSA/NCATS Integration Working Group made recommendations to the NIH Director on how the [Clinical and Translational Science Awards (CTSA) Program](https://ncats.nih.gov/research-research-activities/ctsa "Clinical and Translational Science Awards (CTSA) Program") could be integrated into NCATS.
- Composed of [NIH IC Directors](http://www.nih.gov/icd/icdirectors.htm "Institute Directors - Institutes, Centers Offices - National Institutes of Health (NIH)") (ICD), the ICD-NCATS Working Group made recommendations to the NIH Director about the mission, functions and organization of NCATS.
- The NIH [Scientific Management Review Board](http://smrb.od.nih.gov/ "Scientific Management Review Board") recommended that NIH create a new translational medicine and therapeutics center. [View the December 2010 Report on Translational Medicine and Therapeutics](http://smrb.od.nih.gov/documents/reports/TMAT_122010.pdf "Report on Translational Medicine and Therapeutics") (PDF - 644KB).
**Leadership**
In September 2012, the NIH Director announced the appointment of Christopher P. Austin, M.D., as director of NCATS. When Austin announced his departure in early 2021, Deputy Director Joni L. Rutter, Ph.D., was selected as acting director. In November 2022, Rutter was selected as director of NCATS.
Learn more about [NCATS’ director](https://ncats.nih.gov/about/director/bio) and read the [Director’s Messages](https://ncats.nih.gov/about/director/messages), which highlight the center's priorities.
**Approach**
We are unique in that we focus not on specific diseases, but on what many diseases have in common. Emphasizing the translational science process, we promote three Ds:
- Developing new approaches, technologies, resources and models
- Demonstrating their usefulness
- Disseminating the data, analysis and methodologies to the community
To accomplish the three Ds, the center relies on the power of data, new technologies and teamwork. In this way, we function like an adapter, allowing distinct parts of the research system to connect and collaborate more effectively.
Our approach and mission complement the work of other NIH institutes and centers, the private sector, and the nonprofit community. Collaborations among government, academia, industry and nonprofit patient groups are crucial for successful translation: No organization can succeed alone. To this end, we lead innovative and collaborative approaches in translational science that are crosscutting and useful for the broader scientific community.
**Strategic Plan**
We developed a [strategic plan](https://ncats.nih.gov/sites/default/files/NCATS_strategic_plan.pdf) in 2016 to outline our strategic goals and principles. It is organized into four overarching themes: translational science, collaboration and partnerships, education and training, and stewardship. The themes are captured in the strategic goals and collectively provide an overview of what the center plans to accomplish to achieve its mission.
Learn about our [current strategic planning process](https://ncats.nih.gov/about/ncats-overview/strategic-plan).
Sponsor Relationship
National Center for Advancing Translational Sciences is a part of:
The following sponsors are parts of National Center for Advancing Translational Sciences:
Most Recent Grants from This Sponsor
Funding Opportunity Number: PAR-25-220
The National Institutes of Health (NIH) Tackling...
Funding Opportunity Number: PAR-25-217
**Purpose**
The National Institutes of Health (NIH)...
Funding Opportunity Number: RFA-HL-26-015
Since its inception in 1982, the NIH SBIR program...
**NPKUA Development/Validation of Function-Based Neurocognitive Testing Tools**
**Opportunity...
Deadline Approaching Grants
Funding Opportunity Number: PA-25-212
**Purpose**
The NIH, and the CDC seek to accelerate the...
Notice Number: NOT-OD-25-015
**Purpose**
The NIH Office of Science Policy (OSP) within the...
Funding Opportunity Number: RFA-NS-22-034
**Purpose**
The purpose of this Funding Opportunity...
Funding Opportunity Number: RFA-MD-24-006
**Background**
Despite continued improvement in the...